Published by Coherent Market Insights
Posted on September 14, 2021
Embolization is a minimally invasive treatment procedure that blocks one or more blood vessels or abnormal vascular channels. Embolization procedure requires various types of embolization particles such as radioembolization spheres, drug-eluting beads, microspheres, PVA particles (Polyvinyl Alcohol), and other products such as liquid embolic, plugs, and coils. Embolization procedure is used in the treatment of various chronic diseases such as cancer, uterine fibroid, and other complications of chronic diseases. The academic and research institutes are focusing on the research and development in embolization PVA particles (polyvinyl alcohol), which is expected to drive the market growth over the forecast period
For instance, in April 2019, Washington University School of Medicine, a research university in the U.S., initiated the clinical trial study on Middle Meningeal Artery Embolization with polyvinyl alcohol particles (PVA) on August 2019 and the clinical trial study is expected to be completed by January 1, 2022
Request Sample Copy + related graphs of the report@ https://www.coherentmarketinsights.com/insight/request-sample/4473
Researchers and key players are focusing on the development of novel embolization products for the treatment of chronic diseases such as tumor, hemorrhage and others, which is expected to drive growth of the global embolization market over the forecast period.
For instance, in January 2021, MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, received the U.S. Food and Drug Administration approval for its PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System, is designed with the latest MicroBraid technology, which features a lower profile delivery system compatible with the VIA 17 microcatheter, and includes additional device configurations.
Moreover, in November 2020, Fluidx Medical Technology, a U.S.-based embolic devices manufacturing company, introduced its novel GPX Embolic Device. It is an innovative embolic designed to combine the benefits of other embolics such as coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term occlusions.
Detailed Segmentation:
By Product Type:
By Indication:
By End User:
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4473
Major players operating in the global embolization market include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Embolization Market is Expanding Rapidly as Top Manufacturers IMBiotechnologies Ltd., ABK Biomedical, EmboMedics, Guerbet appeared first on Gatorledger.
Embolization is a minimally invasive treatment procedure that blocks one or more blood vessels or abnormal vascular channels. Embolization procedure requires various types of embolization particles such as radioembolization spheres, drug-eluting beads, microspheres, PVA particles (Polyvinyl Alcohol), and other products such as liquid embolic, plugs, and coils. Embolization procedure is used in the treatment of various chronic diseases such as cancer, uterine fibroid, and other complications of chronic diseases. The academic and research institutes are focusing on the research and development in embolization PVA particles (polyvinyl alcohol), which is expected to drive the market growth over the forecast period
For instance, in April 2019, Washington University School of Medicine, a research university in the U.S., initiated the clinical trial study on Middle Meningeal Artery Embolization with polyvinyl alcohol particles (PVA) on August 2019 and the clinical trial study is expected to be completed by January 1, 2022
Request Sample Copy + related graphs of the report@ https://www.coherentmarketinsights.com/insight/request-sample/4473
Researchers and key players are focusing on the development of novel embolization products for the treatment of chronic diseases such as tumor, hemorrhage and others, which is expected to drive growth of the global embolization market over the forecast period.
For instance, in January 2021, MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, received the U.S. Food and Drug Administration approval for its PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System, is designed with the latest MicroBraid technology, which features a lower profile delivery system compatible with the VIA 17 microcatheter, and includes additional device configurations.
Moreover, in November 2020, Fluidx Medical Technology, a U.S.-based embolic devices manufacturing company, introduced its novel GPX Embolic Device. It is an innovative embolic designed to combine the benefits of other embolics such as coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term occlusions.
Detailed Segmentation:
By Product Type:
By Indication:
By End User:
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4473
Major players operating in the global embolization market include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Embolization Market is Expanding Rapidly as Top Manufacturers IMBiotechnologies Ltd., ABK Biomedical, EmboMedics, Guerbet appeared first on Gatorledger.
Explore more articles in the Research Reports category
